Tuberculosis Infection Screening and Treatment in People Living with Human Immunodeficiency Virus in Custody Within the Illinois Department of Corrections Managed by an Academic Multidisciplinary Telemedicine Service

Background: People with human immunodeficiency virus (PWH and HIV) experiencing incarceration have overlapping risk factors for tuberculosis (TB). This study evaluated TB IGRA screening, diagnosis and treatment among PWH in custody within the Illinois Department of Corrections (IDOC). Methods: This retrospective descriptive cohort study included adults with HIV receiving care through the University of Illinois Health (UIH) HIV telemedicine service from January 2021 to October 2024. Reincarcerations were evaluated as unique intake encounters, where screening could once again take place. Outcomes included TB IGRA screen result, diagnosis of latent TB infection (LTBI) or active TB, TB treatment appropriateness, drug + drug interactions (DDIs), and HIV virologic and immunologic outcomes. Results: Among 258 intake encounters, 219 (84.9%) received TB screening at intake. Of 39 encounters without intake screening, 30 were subsequently screened following UIH’s HIV telemedicine recommendations, resulting in 249 (96.5%) total screens. Of these, 238 (95.6%) were negative, 6 (2.4%) indeterminate, and 5 (2.0%) positive. Six people required LTBI treatment, and no active TB was identified. Among the 6 treated for LTBI, 5 relevant DDIs requiring pharmacist intervention were identified. All identified DDIs were mitigated. At release, or LTBI treatment completion, all treated individuals had CD4 counts >200 cells/mm3 and achieved HIV virologic suppression. Conclusions: TB screening was completed in most PWH within IDOC, with UIH telemedicine facilitating screening after missed intake opportunities. LTBI was uncommon, and no active TB was identified. Pharmacists identified that frequent DDIs among individuals receiving LTBI treatment highlight the importance of intercollaboration and targeted education regarding TB + HIV treatment regimens in correctional settings.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-17
DOI
https://doi.org/10.3390/jcm15229007
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tuberculosis Infection Screening and Treatment in People Living with Human Immunodeficiency Virus in Custody Within the Illinois Department of Corrections Managed by an Academic Multidisciplinary Telemedicine Service

Emily N. Drwiega, Scott A. Borgetti, Melissa E. Badowski, Diane McKelvey et al.
Journal of Clinical Medicine
Tuberculosis Research and Epidemiology
article

Tuberculosis Infection Screening and Treatment in People Living with Human Immunodeficiency Virus in Custody Within the Illinois Department of Corrections Managed by an Academic Multidisciplinary Telemedicine Service

Emily N. Drwiega, Scott A. Borgetti, Melissa E. Badowski, Diane McKelvey, Mahesh C. Patel, Tommy Windt, Luke Stickler
article en

Abstract

Background: People with human immunodeficiency virus (PWH and HIV) experiencing incarceration have overlapping risk factors for tuberculosis (TB). This study evaluated TB IGRA screening, diagnosis and treatment among PWH in custody within the Illinois Department of Corrections (IDOC). Methods: This retrospective descriptive cohort study included adults with HIV receiving care through the University of Illinois Health (UIH) HIV telemedicine service from January 2021 to October 2024. Reincarcerations were evaluated as unique intake encounters, where screening could once again take place. Outcomes included TB IGRA screen result, diagnosis of latent TB infection (LTBI) or active TB, TB treatment appropriateness, drug + drug interactions (DDIs), and HIV virologic and immunologic outcomes. Results: Among 258 intake encounters, 219 (84.9%) received TB screening at intake. Of 39 encounters without intake screening, 30 were subsequently screened following UIH’s HIV telemedicine recommendations, resulting in 249 (96.5%) total screens. Of these, 238 (95.6%) were negative, 6 (2.4%) indeterminate, and 5 (2.0%) positive. Six people required LTBI treatment, and no active TB was identified. Among the 6 treated for LTBI, 5 relevant DDIs requiring pharmacist intervention were identified. All identified DDIs were mitigated. At release, or LTBI treatment completion, all treated individuals had CD4 counts >200 cells/mm3 and achieved HIV virologic suppression. Conclusions: TB screening was completed in most PWH within IDOC, with UIH telemedicine facilitating screening after missed intake opportunities. LTBI was uncommon, and no active TB was identified. Pharmacists identified that frequent DDIs among individuals receiving LTBI treatment highlight the importance of intercollaboration and targeted education regarding TB + HIV treatment regimens in correctional settings.

Journal of Clinical MedicineVol. 15(22)
University of Illinois Chicago (US), University of Illinois Hospital & Health Sciences System (US)
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon